(4/5) To highlight my point in the previous $VIVO post, here are 5 other charts in the Biotech sector that have shown relative strength lately. Don't get me wrong, the market is still on a downtrend, but should we reverse and start a new uptrend, this sector may potentially be the next one to lead a new bull market.
Daily hammer after 100% correction. Need to confirm hammer for short entry
HALO: Halozyme Therapeutics, Inc. 2021-12-09 16:00:00 HALOZYME ANNOUNCES $750 MILLION THREE-YEAR SHARE REPURCHASE PROGRAM
waiting for closing 1D lower 44.53 Short on retest from downside. Goal is 42
HALO: Halozyme Therapeutics, Inc. 2021-01-15 17:00:00 Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASPRO® (Daratumumab And Hyaluronidase-fihj) As Treatment For Newly Diagnosed Patients With Light Chain (AL) Amyloidosis
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on...
Yet another #biotech #breakout - Latest quarter showed a +290% earnings improvement. This #biopharma has a $4B market cap. Watching, not buying.
Hey people, HALOZYME THERAPEUTICS is in a bullish continuation a small rejection of the sellers but that changes to nothing large volume of purchases made. Great possibility of breaking with force the median this time to reach the next point, which is the double of the candle and to start again lower if the buyers are too expensive. Please LIKE & FOLLOW, thank you!!
HALO: Halozyme Therapeutics, Inc. 2020-06-29 12:54:00 Halozyme Announces Roche Receives FDA Approval For Phesgo(TM) (Fixed-Dose Combination Of Perjeta® And Herceptin® For Subcutaneous Injection) Utilizing Halozyme's ENHANZE® Technology For The Treatment Of Patients With HER2-Positive Breast Cancer
Hello, What is HALO? Halozyme Therapeutics is a U.S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. News My...
Halozyme Therapeutics (#HALO - US) is in ABC pattern and out-performing the SPX. It is in internal 4th wave correction of 3rd wave of C up. Buy at the price within box, if possible for the new high as target.
Using our Elliott Wave Indicator Suite for the TradingView Platform we have identified a potential Long 5th Wave Swing Trading Opportunity for HALO on the Daily time frame . The 5th wave move in an elliottwave sequence is the highest probability move. The large impulse moves, waves 1 and 3, were obvious news events with large volume. The volume on the wave 4...
This is based purely on Fib retracements and trend-based timing.
$HALO 13.12 Found support on Trend Line. Bullish
Could go long on this retest of the accumulation zone. Price Target $18.50.
12.75 is the hold here. If can hold this and come back with a bullish candle to follow up this should be a good r/r here.